Regulatory Intelligence in Pharmacovigilance

"As part of our ongoing regulatory intelligence activities,
QVigilance team actively monitors websites, newsletters,
and RSS feeds of regulatory authorities and international
standards organisations; as well as reviewing
relevant articles and blogs"

Esther Poole
PHARMACOVIGILANCE SPECIALIST

Ongoing Monitoring Services

QVigilance continuously monitors regulatory information from local, regional and global authorities and organisations for pharmacovigilance-related regulatory intelligence to ensure that we and our customers are always up to speed and thereby maintain compliance with the latest regulatory requirements and guidelines for both investigational and authorised products.

OUR OFFER

Regulatory Intelligence Services:

Reg. Int - IMG 2.jpg
REQUEST OUR REGULATORY INTELLIGENCE SERVICES TO MANTAIN COMPLIANCE

Get in touch with our experts!

Submit an RFI

5977730031

UK Draft Contingency released for ...

13 Feb, 2019

The UK government has released draft legislation amending the regulation of authorised Medicinal Products, Medical Devices and Clinical Trials, to be implemented in the event that the UK leaves the European Union (EU) ...

Read More

‘No deal’ Brexit regulatory advice ...

06 Dec, 2018

In this 'Brexit News' close-up our Regulatory Intelligence team will provide a commentary and updates on recent British Government briefing around Brexit implication on medicines, devices and clinical trials. Also, will ...

Read More

Pharmacovigilance in the European ...

06 Dec, 2018

To ensure a smooth transition from the pre-authorisation to the post-authorisation phase of the life-cycle of a medicinal product, it is the responsibility of the Marketing Authorisation (MA) applicant to have in place ...

Read More